Our funding programs support early stage, Ohio-based companies to achieve success.


Athersys is a Cleveland, Ohio based company developing a growing pipeline of therapeutics designed to treat cardiovascular disease and other conditions. Athersys is currently developing pharmaceutical-like cell therapies, based upon its proprietary multipotent adult progenitor cell technology, for the treatment of congestive heart failure, acute myocardial infarction and other cardiovascular conditions.

view all portfolio companies

Global Cardiovascular Innovation Center